Home › Astrocytoma › Pennsylvania › Pittsburgh
Astrocytoma clinical trials in Pittsburgh, PA
3 studies for Astrocytoma are looking for participants at sites in and around Pittsburgh (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
RecruitingPhase 1
- UPMC Hillman Cancer Center, Pittsburgh
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
RecruitingPhase 3
- Allegheny General Hospital, Pittsburgh
- UPMC Hillman Cancer Center, Pittsburgh
- UPMC-Shadyside Hospital, Pittsburgh
- and 2 more
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 3
- UPMC Hillman Cancer Center, Pittsburgh
Astrocytoma trials in other cities
- Houston, TX14 studies
- Boston, MA13 studies
- New York City, NY9 studies
- Chicago, IL9 studies
- Miami, FL7 studies
- Seattle, WA7 studies
- Philadelphia, PA7 studies
- Washington, DC6 studies
- Durham, NC6 studies
- Columbus, OH6 studies
- San Francisco, CA5 studies
- Aurora, CO5 studies
Other studies in Pittsburgh
- Non-Small Cell Lung Cancer48 studies
- Cancer (all types)42 studies
- Breast Cancer39 studies
- Colorectal Cancer32 studies
- Melanoma31 studies
- Metastatic Cancer31 studies
- Ovarian Cancer30 studies
- Endometrial Cancer24 studies
- Lung Cancer23 studies
- Prostate Cancer23 studies
- Stroke22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.